CytoDyn Inc. filed a Form D with the Securities and Exchange Commission on 2026-05-11.
CytoDyn Inc. filed a Form D notice of an exempt securities offering with the SEC on May 11, 2026. CytoDyn Inc. trades on OTC as CYDY. The filing reports $18.60M sold. Its industry group is Pharmaceuticals. It names Jacob Lalezari (Executive Officer), Robert Hoffman (Executive Officer), Tyler Blok (Executive Officer) (SEC Form D, May 11, 2026).
In its own words: “CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).” (cytodyn.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like CytoDyn Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-05-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns CytoDyn Inc.
Free to see. No signup.
More on the people and the money behind CytoDyn Inc., from the filings we hold.
Paulson Investment Company received sales compensation on this raise and on 9 other raises we hold, nearest in date first:
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when CytoDyn Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when CytoDyn Inc. raises, hires or launches. No email unless you switch it on.
Watch CytoDyn Inc. →Get the full cited report on CytoDyn Inc.
What the filing shows about CytoDyn Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CytoDyn Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives CytoDyn Inc.'s address as 1111 Main Street, Suite 660, Vancouver, WA 98660.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
CytoDyn Inc. is a registered filer with the SEC (CIK 1175680) and has filed since 2026-05-11. 1 filing is on record, the latest on 2026-05-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
CytoDyn Inc.'s Form D of 2026-05-11 names Jacob Lalezari, Robert Hoffman, Tyler Blok and 5 more as its officers, directors or promoters.
Its new offerings report $18.60M sold across 1 offering, as its own filings state.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $18.60M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
The title and description the site itself served, answering 200, after redirecting from https://cytodyn.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Jacob Lalezari is named as Executive Officer on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Robert Hoffman is named as Executive Officer on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Tyler Blok is named as Executive Officer on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Lishomwa Ndhlovu, M.D., Ph.D. is named as Director on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Karen Brunke, Ph.D. is named as Director on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Ryan Dunlap is named as Director on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Tanya Urbach is named as Director on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
Stephen Simes is named as Director on the Form D that CytoDyn Inc. filed with the SEC on 11 May 2026, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2026-05-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about CytoDyn Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CytoDyn Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CytoDyn Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CytoDyn Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind CytoDyn Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (cytodyn.com).
Each opens in a new tab, filled in for CytoDyn Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cytodyn-inc-form-d-26000001